←Back to Expert Scholars
Translational Medicine / 转化医学Bispecific Antibodies, Lymphoma
Kai Hubel
MD
🏢University Hospital Cologne🌐Germany
Professor of Hematology and Oncology
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Kai Hubel is a German hematologist at Cologne who has contributed to bispecific antibody trials in DLBCL including epcoritamab and glofitamab studies. He has led studies of novel agents in relapsed NHL. His work informs German and European lymphoma practice.
Share:
🧪Research Fields 研究领域
bispecific antibodies
DLBCL
German lymphoma
epcoritamab
relapsed NHL
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kai Hubel 的研究动态
Follow Kai Hubel's research updates
留下邮箱，当我们发布与 Kai Hubel（University Hospital Cologne）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment